TITLE

Genome wide scan in a Flemish inflammatory bowel disease population: support for the IBD4 locus, population heterogeneity, and epistasis

AUTHOR(S)
Vermeire, S.; Rutgeerts, P.; Von Steen, K.; Joossens, S.; Cloessens, G.; Pierik, M.; Peeters, M.; Vlietinck, R.
PUB. DATE
July 2004
SOURCE
Gut;Jul2004, Vol. 53 Issue 7, p980
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background and aims: Genome wide scans in inflammatory bowel disease (IBD) have indicated various susceptibility regions with replication of 16cen (IBD1), 12q (IBD2), 6p (IBD3), 14q11 (IBD4), and 3p21. As no linkage was previously found on IBD regions 3, 7, 12, and 16 in Flemish IBD families, a genome wide scan was performed to detect other susceptibility regions in this population. Methods: A cohort of 149 IBD affected relative pairs, all recruited from the Northern Flemish part of Belgium, were genotyped using microsatellite markers at 12 cM intervals, and analysed by Genehunter non-parametric linkage software. All families were further genotyped for the three main Crohn's disease associated variants in the NOD2/CARD15 gene. Results: Nominal evidence for linkage was observed on chromosomes 1 (D1S197: multipoint non-parametric linkage (NPL) score 2.57, p=0.004; and at D1S305-D1S252: NPL 2.97, p=0.001), 4q (D4S406: NPL 1.95, p=0.03), 6q16 (D6S314: NPL 2.44, p=0.007), 10p12 (D10S197: NPL 2.05, p=0.02), 11q22 (D11S35-D11S927: NPL 1.95, p=0.02) 14q11-12 (D14S80: NPL 2.41, p=0.008), 20p12 (D20S192: NPL 2.7, p=0.003), and Xq (DXS990: NPL 1.70, p=0.04). A total of 51.4% of patients carried at least one NOD2/CARD15 variant. Furthermore, epistasis was observed between susceptibility regions 6q/10p and 20p/10p. Conclusion: Genome scanning in a Flemish IBD population found nominal evidence for linkage on 1p, 4q, 10p12, and 14q11, overlapping with other genome scan results, with linkage on 14q11-12 supporting the IBD4 locus. The results further show that epistasis is contributing to the complex model of IBD and indicate that population heterogeneity is not to be underestimated. Finally, NOD2/CARD15 is clearly implicated in the Flemish IBD population.
ACCESSION #
13870129

 

Related Articles

  • Genetic background of inflammatory bowel disease. Dobrowolska-Zachwieja, Agnieszka; Linke, Krzysztof; Jakubowska-Burek, Ludwika; Kucharski, Marcin // Gastroenterologia Polska / Gastroenterology;2009, Vol. 16 Issue 6, p421 

    Genetic predisposition is in the background of many human diseases, also gastroenterological ones. A group of diseases widely researched in recent years with regard to genetic factors is inflammatory bowel disease, two main entities of which are Crohn's disease and ulcerative colitis. Numerous...

  • Analysis of the NOD2 / CARD15 Gene in Patients Affected with the Aseptic Abscesses Syndrome with or without Inflammatory Bowel Disease. Olivier Aumaître; Jean-Charles Piette; Marie-Céleste Cardoso; Jean-Louis Kémény // Digestive Diseases & Sciences;Feb2008, Vol. 53 Issue 2, p490 

    Abstract Objectives   NOD2/CARD15 is a susceptibility gene for Crohn’s disease (CD). It is also involved, via different mutations, in the Blau syndrome. The syndrome of aseptic abscesses (AA) is characterized by visceral sterile collections of mature neutrophils that...

  • A Genome-Wide Scan of Ashkenazi Jewish Crohn's Disease Suggests Novel Susceptibility Loci. Kenny, Eimear E.; Pe'er, Itsik; Karban, Amir; Ozelius, Laurie; Mitchell, Adele A.; Sok Meng Ng; Erazo, Monica; Ostrer, Harry; Abraham, Clara; Abreu, Maria T.; Atzmon, Gil; Barzilai, Nir; Brant, Steven R.; Bressman, Susan; Burns, Edward R.; Chowers, Yehuda; Clark, Lorraine N.; Darvasi, Ariel; Doheny, Dana; Duerr, Richard H. // PLoS Genetics;Mar2012, Vol. 8 Issue 3, Special section p1 

    Crohn's disease (CD) is a complex disorder resulting from the interaction of intestinal microbiota with the host immune system in genetically susceptible individuals. The largest meta-analysis of genome-wide association to date identified 71 CD--susceptibility loci in individuals of European...

  • Common pathways in Crohn's disease and other inflammatory diseases revealed by genomics. Massey, Dunecan; Parkes, Miles // Gut;Nov2007, Vol. 56 Issue 11, p1489 

    Genetics may not provide all the answers but it will, in highlighting the pathways relevant to the pathogenesis of Crohn's disease and other inflammatory conditions, at least indicate which questions need answering

  • Inflammatory bowel disease: Genetic and epidemiologic considerations. Co, Judy H. // World Journal of Gastroenterology;1/21/2008, Vol. 14 Issue 3, p338 

    Genome-wide association studies have firmly established that many genomic loci contribute to inflammatory bowel disease, especially in Crohn's disease. These studies have newly-established the importance of the interleukin 23 and autophagy pathways in disease pathogenesis. Future challenges...

  • Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci. Melum, Espen; Franke, Andre; Schramm, Christoph; Weismüller, Tobias J.; Gotthardt, Daniel Nils; Offner, Felix A.; Juran, Brian D.; Laerdahl, Jon K.; Labi, Verena; Björnsson, Einar; Weersma, Rinse K.; Henckaerts, Liesbet; Teufel, Andreas; Rust, Christian; Ellinghaus, Eva; Balschun, Tobias; Boberg, Kirsten Muri; Ellinghaus, David; Bergquist, Annika; Sauer, Peter // Nature Genetics;Jan2011, Vol. 43 Issue 1, p17 

    Primary sclerosing cholangitis (PSC) is a chronic bile duct disease affecting 2.4-7.5% of individuals with inflammatory bowel disease. We performed a genome-wide association analysis of 2,466,182 SNPs in 715 individuals with PSC and 2,962 controls, followed by replication in 1,025 PSC cases and...

  • World Gastroenterology Organisation Global Guideline: Inflammatory bowel disease: a global perspective - June 2009. Bernstein, Charles N.; Fried, Michael; Krabshuis, J. H.; Cohen, Henry; Eliakim, R.; Fedail, Suleiman; Gearry, Richard; Goh, K. L.; Hamid, Saheed; Khan, Aamir Ghafor; LeMair, A. W.; Malfertheiner, P.; Qin Ouyang; Rey, J.-F.; Sood, Ajit; Steinwurz, Flavio; Thomsen, Ole �.; Thomson, Alan; Watermeyer, Gillian // South African Gastroenterology Review;Aug2010, Vol. 8 Issue 2, p13 

    The article presents the global guideline for inflammatory bowel disease (IBD) from the World gastroenterology Organisation. It notes that IBD contains a group of idiopathic chronic inflammatory intestinal illnesses which has two main disease types such as Crohn's disease (CD) and ulcerative...

  • Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease. Momozawa, Yukihide; Mni, Myriam; Nakamura, Kayo; Coppieters, Wouter; Almer, Sven; Amininejad, Leila; Cleynen, Isabelle; Colombel, Jean-Frédéric; de Rijk, Peter; Dewit, Olivier; Finkel, Yigael; Gassull, Miquel A.; Goossens, Dirk; Laukens, Debby; Lémann, Marc; Libioulle, Cécile; O'Morain, Colm; Reenaers, Catherine; Rutgeerts, Paul; Tysk, Curt // Nature Genetics;Jan2011, Vol. 43 Issue 1, p43 

    Genome-wide association studies (GWAS) have identified dozens of risk loci for many complex disorders, including Crohn's disease. However, common disease-associated SNPs explain at most ∼20% of the genetic variance for Crohn's disease. Several factors may account for this unexplained...

  • MDR1 C3435T polymorphism and inflammatory bowel disease risk: a meta-analysis. Wang, Jun; Guo, Xufeng; Yu, Shijie; Zhang, Jixiang; Song, Jia; Ji, Mengyao; Cao, Zhuo; Wang, Jing; Liu, Ya; Dong, Weiguo // Molecular Biology Reports;Apr2014, Vol. 41 Issue 4, p2679 

    The C3435T polymorphism of the multidrug resistance gene ( MDR1) has been implicated in inflammatory bowel disease (IBD) risk, but the reported results are inconsistent. Here we performed a meta-analysis to evaluate the association between C3435T polymorphism and the risk of IBD using all...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics